Morris C D, Menashe V D, Anderson P H, Malinow M R, Illingworth D R
Department of Medicine, Oregon Health Sciences University, Portland 97201.
Prev Med. 1990 Sep;19(5):493-501. doi: 10.1016/0091-7435(90)90048-o.
Population screening or plasma cholesterol is an effective method of detecting hypercholesterolemia; however, follow-up and treatment are essential components of such a program. After a city-wide screening in 1987 of more than 19,872 persons, using a mailed survey with a response rate of 48%, we evaluated subsequent actions of 3,078 individuals with high plasma cholesterol levels. Slightly more than half the population was aware of high blood cholesterol levels prior to the time of screening and apparently used the program for follow-up. Overall, after the screening, 65% consulted a physician within 5 months of screening and blood cholesterol levels were remeasured in 80% of the sample. Procrastination and expense were cited as the primary reasons for failing to consult a physician. If screening is to be effectively utilized as a means of reducing the prevalence of high plasma cholesterol levels, diligent follow-up must be made of all individuals identified to be at increased risk on the basis of their initial values.
人群筛查或血浆胆固醇检测是检测高胆固醇血症的有效方法；然而，随访和治疗是该项目的重要组成部分。1987年在全市范围内对19872多人进行了筛查，采用邮寄调查问卷的方式，回复率为48%，我们评估了3078名血浆胆固醇水平高的个体随后的行动。略多于一半的人群在筛查前就知道自己血胆固醇水平高，并且显然利用该项目进行了随访。总体而言，筛查后，65%的人在筛查后5个月内咨询了医生，80%的样本重新测量了血胆固醇水平。拖延和费用被认为是未咨询医生的主要原因。如果要有效地利用筛查作为降低高血浆胆固醇水平患病率的手段，就必须对所有根据初始值确定为风险增加的个体进行认真随访。
